These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 8801208)
21. Protective effects of Rosmarinus tomentosus ethanol extract on thioacetamide-induced liver cirrhosis in rats. Galisteo M; Suárez A; Montilla MP; Torres MI; Gil A; Navarro MC Phytomedicine; 2006 Jan; 13(1-2):101-8. PubMed ID: 16360939 [TBL] [Abstract][Full Text] [Related]
22. Chronic liver injury by thioacetamide and promotion of hepatic carcinogenesis. Gervasi PG; Longo V; Marzano M; Saviozzi M; Malvaldi G J Cancer Res Clin Oncol; 1989; 115(1):29-35. PubMed ID: 2921270 [TBL] [Abstract][Full Text] [Related]
23. Rapid development of hyperplastic nodules and cirrhosis in the liver of rats treated concurrently with thioacetamide and the pyrrolizidine alkaloid lasiocarpine. Reddy JK; Rao MS; Jago MV Int J Cancer; 1976 May; 17(5):621-5. PubMed ID: 1270177 [TBL] [Abstract][Full Text] [Related]
24. The antifibrogenic effect of etanercept on development of liver cirrhosis induced by thioacetamide in rats. Abdul-Hamid M; Ahmed RR; Moustafa N; Nady R Ultrastruct Pathol; 2017; 41(1):23-35. PubMed ID: 27982723 [TBL] [Abstract][Full Text] [Related]
25. [Protein expression profiles in a rat cirrhotic model induced by thioacetamide]. An JH; Seong J; Oh H; Kim W; Han KH; Paik YH Korean J Hepatol; 2006 Mar; 12(1):93-102. PubMed ID: 16565610 [TBL] [Abstract][Full Text] [Related]
26. Role of selenium in protection of liver cirrhosis. Fatima SN; Mahboob T Pak J Pharm Sci; 2013 Nov; 26(6):1097-102. PubMed ID: 24191312 [TBL] [Abstract][Full Text] [Related]
27. [Modifications of the enzymatic content and morphology of the exocrine pancreas of rats with experimental hepatic cirrhosis induced by thioacetamide]. Santamaría Gil ME; de Andrés Loste MS; Fernández Alonso MC; González Fernández E; Blanco Varela FJ; Coca García MC; Caro-Patón Gómez A An Med Interna; 1991 Dec; 8(12):601-4. PubMed ID: 1723629 [TBL] [Abstract][Full Text] [Related]
28. Bacterial translocation in thioacetamide induced liver cirrhosis in rats. al-Bader AA; Mathew TC; Abul H; al-Mosawi M; Panigrahi D; Dashti H J R Coll Surg Edinb; 1998 Aug; 43(4):278-82. PubMed ID: 9735658 [TBL] [Abstract][Full Text] [Related]
29. Modulation of extracellular matrix by nutritional hepatotrophic factors in thioacetamide-induced liver cirrhosis in the rat. Guerra RR; Trotta MR; Parra OM; Avanzo JL; Bateman A; Aloia TP; Dagli ML; Hernandez-Blazquez FJ Braz J Med Biol Res; 2009 Nov; 42(11):1027-34. PubMed ID: 19784507 [TBL] [Abstract][Full Text] [Related]
30. Alteration in growth regulation of hepatocytes in primary culture obtained from cirrhotic rat: poor response to transforming growth factor-beta 1 and interferons. Kiso S; Kawata S; Tamura S; Ito N; Takaishi K; Shirai Y; Tsushima H; Matsuzawa Y Hepatology; 1994 Nov; 20(5):1303-8. PubMed ID: 7523274 [TBL] [Abstract][Full Text] [Related]
31. Effect of a parenteral nucleoside-nucleotide mixture on hepatic metabolism in partially hepatectomized cirrhotic rats. Usami M; Iso A; Kasahara H; Kotani G; Haji S; Kanamaru T; Saitoh Y Nutrition; 1996 Jun; 12(6):436-9. PubMed ID: 8875539 [TBL] [Abstract][Full Text] [Related]
32. Alterations to hepatic microcirculation in thioacetamide-induced cirrhotic livers of rats. Nakata M; Nakamura K; Koda Y; Kaminou T; Ogami M; Yamada R Osaka City Med J; 2002 Jun; 48(1):1-8. PubMed ID: 12375692 [TBL] [Abstract][Full Text] [Related]
33. Protective effect of alpha-mangostin against type-I collagen formation in thioacetamide-induced cirrhotic rat. Poonkhum R; Watanapokasin R; Pradidarcheep W J Med Assoc Thai; 2012 Dec; 95 Suppl 12():S93-8. PubMed ID: 23513472 [TBL] [Abstract][Full Text] [Related]
34. Experimental thioacetamide-induced cirrhosis of the liver. Muñoz Torres E; Paz Bouza JI; López Bravo A; Abad Hernández MM; Carrascal Marino E Histol Histopathol; 1991 Jan; 6(1):95-100. PubMed ID: 1806061 [TBL] [Abstract][Full Text] [Related]
35. Analysis of the nitric oxide-cyclic guanosine monophosphate pathway in experimental liver cirrhosis suggests phosphodiesterase-5 as potential target to treat portal hypertension. Schaffner D; Lazaro A; Deibert P; Hasselblatt P; Stoll P; Fauth L; Baumstark MW; Merfort I; Schmitt-Graeff A; Kreisel W World J Gastroenterol; 2018 Oct; 24(38):4356-4368. PubMed ID: 30344420 [TBL] [Abstract][Full Text] [Related]
36. Hemodynamics in the microvasculature of thioacetamide-induced cirrhotic rat livers. Nakata M; Nakamura K; Koda Y; Kaminou T; Ugami M; Kaneda K; Yamada R Hepatogastroenterology; 2002; 49(45):652-6. PubMed ID: 12063962 [TBL] [Abstract][Full Text] [Related]
37. Thioacetamide potentiates high cholesterol and high fat diet induced steato-hepatitic changes in livers of C57BL/6J mice: A novel eight weeks model of fibrosing NASH. Sharma L; Gupta D; Abdullah ST Toxicol Lett; 2019 Apr; 304():21-29. PubMed ID: 30625377 [TBL] [Abstract][Full Text] [Related]
38. Cholangiocarcinoma and liver cirrhosis in relation to changes due to thioacetamide. Al-Bader A; Mathew TC; Abul H; Al-Sayer H; Singal PK; Dashti HM Mol Cell Biochem; 2000 May; 208(1-2):1-10. PubMed ID: 10939622 [TBL] [Abstract][Full Text] [Related]
39. Population of hepatic macrophages and response of perfused liver to platelet-activating factor during production of thioacetamide-induced cirrhosis in rats. Noda S; Masumi S; Moriyama M; Kannan Y; Ohta M; Sugano T; Yamate J Hepatology; 1996 Aug; 24(2):412-8. PubMed ID: 8690413 [TBL] [Abstract][Full Text] [Related]
40. Protective effects of recombinant human growth hormone on cirrhotic rats. Chen S; Wang HT; Yang B; Fu YR; Ou QJ World J Gastroenterol; 2004 Oct; 10(19):2894-7. PubMed ID: 15334695 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]